| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jan―17 |
Exploring the long-term neurological consequences of COVID-19 |
Heather Wood |
| 2 |
[GO] |
2023―May―03 |
Olfactory network function altered in COVID-19 |
Sarah Lemprière |
| 3 |
[GO] |
2022―Nov―02 |
Preventing COVID-19 neurological complications |
Lisa Kiani |
| 4 |
[GO] |
2022―Jun―30 |
Inflammation links mild COVID-19 with long-term cognitive impairment |
Sarah Lemprière |
| 5 |
[GO] |
2022―Apr―21 |
Brain changes after COVID-19 - how concerned should we be? |
Stéphane Kremer, H. Rolf Jäger |
| 6 |
[GO] |
2022―Feb―04 |
Third COVID-19 jab benefits people with MS |
Sarah Lemprière |
| 7 |
[GO] |
2021―Dec―20 |
High rate of epilepsy in young individuals who died with COVID-19 |
Sarah Lempriere |
| 8 |
[GO] |
2021―Dec―20 |
Risk-benefit analysis of COVID-19 vaccines - a neurological perspective |
Colleen L. Lau, Ian Galea |
| 9 |
[GO] |
2021―Dec―09 |
Safety and efficacy of COVID-19 vaccines in people with neurological disorders |
Heather Wood |
| 10 |
[GO] |
2021―Nov―18 |
Counting the neurological cost of COVID-19 |
Abdul Mannan Baig |
| 11 |
[GO] |
2021―Oct―22 |
T cells step up after SARS-CoV-2 vaccination with B cell depletion |
Thomas Berger, Barbara Kornek |
| 12 |
[GO] |
2021―Sep―03 |
Neurological manifestations of rhino-oculo-cerebral mucormycosis in the COVID-19 era |
Gagandeep Singh, Venugopalan Y. Vishnu |
| 13 |
[GO] |
2021―Sep―03 |
Multiple sclerosis relapses not associated with mRNA COVID-19 vaccine |
Ian Fyfe |
| 14 |
[GO] |
2021―Aug―09 |
Multiple sclerosis treatment blunts SARS-CoV-2 antibody response |
Sarah Lemprière |
| 15 |
[GO] |
2021―Jul―07 |
Single-cell transcriptomics reveals neuroinflammation in severe COVID-19 |
Sarah Lemprière |
| 16 |
[GO] |
2021―Apr―27 |
COVID-19 dominates discussions at AAN 2021 |
Heather Wood |
| 17 |
[GO] |
2021―Mar―24 |
Reply to: Neuroimmune interactions and COVID-19 in lung transplant recipients |
Francesco De Virgiliis, Simone Di Giovanni |
| 18 |
[GO] |
2021―Mar―24 |
Neuroimmune interactions and COVID-19 in lung transplant recipients |
Joan Arenas-Prat |
| 19 |
[GO] |
2021―Feb―20 |
Elevated risk of COVID-19 in people with dementia |
Heather Wood |
| 20 |
[GO] |
2021―Feb―09 |
COVID-19 database launched in the USA |
Ian Fyfe |
| 21 |
[GO] |
2021―Jan―07 |
Inequities in neurology amplified by the COVID-19 pandemic |
LaShyra Nolen, Nicte I. Mejia |
| 22 |
[GO] |
2021―Jan―07 |
Neurological infection with SARS-CoV-2 - the story so far |
Tom Solomon |
| 23 |
[GO] |
2021―Jan―06 |
The effects of the COVID-19 pandemic on people with dementia |
Katya Numbers, Henry Brodaty |
| 24 |
[GO] |
2021―Jan―04 |
SARS-CoV-2 detected in olfactory neurons |
Sarah Lemprière |
| 25 |
[GO] |
2020―Dec―18 |
COVID-19 and the neurological disease therapeutic pipeline |
Gregory A. Jicha, Erin L. Abner |
| 26 |
[GO] |
2020―Nov―30 |
Neurological telemedicine in the COVID-19 era |
Victor Patterson |
| 27 |
[GO] |
2020―Sep―03 |
Publisher Correction: SARS-CoV-2 and the brain to be studied long-term |
Sarah Lemprière |
| 28 |
[GO] |
2020―Aug―27 |
SARS-CoV-2 and the brain to be studied long-term |
Sarah Lemprière |
| 29 |
[GO] |
2020―Aug―25 |
Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19 |
Francesco De Virgiliis, Simone Di Giovanni |
| 30 |
[GO] |
2020―Aug―24 |
Lifting the mask on neurological manifestations of COVID-19 |
Alessandro Pezzini, Alessandro Padovani |
| 31 |
[GO] |
2020―Jul―22 |
Author Correction: Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature |
Catharina Korsukewitz, Stephen W. Reddel, Amit Bar-Or, Heinz Wiendl |
| 32 |
[GO] |
2020―Jul―08 |
Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature |
Catharina Korsukewitz, Stephen W. Reddel, Amit Bar-Or, Heinz Wiendl |
| 33 |
[GO] |
2020―Jun―26 |
New insights into the neurological effects of COVID-19 |
Heather Wood |
| 34 |
[GO] |
2020―May―28 |
Endovascular stroke treatment during the COVID-19 pandemic |
Johanna M. Ospel, Mayank Goyal |
| 35 |
[GO] |
2020―May―22 |
COVID-19 and management of neuroimmunological disorders |
Hans-Peter Hartung, Orhan Aktas |
